Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in High‐Risk Individuals in Australia
Medical Journal of Australia · 2026-07 · 224 (7)
DOI: 10.5694/mja2.70234 ↗Kurz gefasst
Leitlinie in der Zeitschrift Medical Journal of Australia, online erschienen am 13.07.2026. Verfasst von Nicole M Rankin und 30 weiteren Autor:innen. Beteiligte Einrichtung: Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Lung Neoplasms, Early Detection of Cancer, Mass Screening. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancer Australia.
Abstract (Originalsprache)
Introduction Lung cancer is the leading cause of cancer mortality in Australia. In July 2025, the Australian Government launched the National Lung Cancer Screening Program (the Program). The Program has been designed in accordance with the Medical Services Advisory Committee's recommendations. This article summarises the program guidelines, outlining Program parameters and delivery requirements. The screening and assessment pathway defines the Program structure. The purpose of the guidelines is to ensure safe, effective and high‐quality Program delivery, detailing key steps for clinical practice and information for participating healthcare providers. Main Recommendations The guidelines provide recommendations for the delivery of targeted low‐dose CT screening for lung cancer in the Australian context. Program eligibility is assessed using risk‐based eligibility criteria recommended by the Medical Services Advisory Committee, targeting people between 50 and 70 years of age with a history of tobacco cigarette smoking. Smoking cessation supports are to be offered to all potential participants by healthcare providers across the lung cancer screening and assessment pathway. Low‐dose CT scan assessment and reporting follow the National Lung Cancer Screening Program's nodule management protocol. Changes in Management as a Result of the Guideline This guideline provides recommendations for the delivery of targeted low‐dose CT screening for lung cancer in the Australian context. Content includes: guidance on assessing Program eligibility; enrolling eligible participants in the National Cancer Screening Register; completing and fulfilling low‐dose CT scan requests; assessing and reporting low‐dose CT scan results; managing scan outcomes and actionable additional findings; and communicating scan results. The full guideline is available at https://www.health.gov.au/resources/publications/nlcsp‐guidelines .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
- Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
- Yardhura Walani, National Centre for Aboriginal and Torres Strait Islander Wellbeing Research, Australian National University, Acton, Australian Capital Territory, Australia.
- Department of Respiratory Medicine, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
- School of Medicine, The University of Western Australia, Perth, Western Australia, Australia.
- Northern Imaging, Victoria Northern Health NCHER, Epping, Victoria, Australia.
ORCID-Profile: Lisa J Whop, Raglan Maddox, Jon Emery, Maria A R Lantin, Mikayla Wolfe, Alison Brown, Julia Brotherton, Fraser Brims
Förderung
- Cancer Australia
Zitieren
APA
Rankin, N. M., Zosel, R., Whop, L. J., Maddox, R., McWilliams, A., Siemienowicz, M., Emery, J., Lantin, M. A. R., Bartlett, G., Wolfe, M., Diaz, A., Anderson, K., Liu, L., Toms, C., McDermott, S., Bligh, P., Chalke, J., Melsom, S., Nightingale, C. E., …, & Milch, V. (2026). Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in High‐Risk Individuals in Australia. Medical Journal of Australia, 224(7). https://doi.org/10.5694/mja2.70234
Vancouver
Rankin NM, Zosel R, Whop LJ, Maddox R, McWilliams A, Siemienowicz M, et al. Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in High‐Risk Individuals in Australia. Medical Journal of Australia. 2026;224(7). doi:10.5694/mja2.70234
BibTeX
@article{Rankin2026,
author = {Rankin, Nicole M and Zosel, Rebecca and Whop, Lisa J and Maddox, Raglan and McWilliams, Annette and Siemienowicz, Miranda and Emery, Jon and Lantin, Maria A R and Bartlett, Georgia and Wolfe, Mikayla and Diaz, Abbey and Anderson, Katrina and Liu, Lillian and Toms, Cindy and McDermott, Sarah and Bligh, Peter and Chalke, Jeremy and Melsom, Stephen and Nightingale, Claire E and Brown, Alison and Pope, Sam and Brotherton, Julia and Fidler, Anne and Itel, Michel and Brooke, Mark and Pascoe, Diane M and Brims, Fraser and Leong, Tracy L and Stone, Emily and Keefe, Dorothy and Milch, Vivienne},
title = {Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in High‐Risk Individuals in Australia},
journal = {Medical Journal of Australia},
year = {2026},
volume = {224},
number = {7},
doi = {10.5694/mja2.70234}
}
EUVIMED